查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947894

胜肽合成市場分析及預測（至2035年）：依類型、產品、服務、技術、應用、最終用戶、製程、材料及功能分類

Peptide Synthesis Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Process, Material Type, Functionality
出版日期: | 出版商: Global Insight Services | 英文 306 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計胜肽合成市場將從2024年的6.852億美元成長到2034年的22.65億美元，複合年成長率約為19.3%。胜肽合成市場涵蓋胜肽的生產，胜肽是由胺基酸鏈組成的，對藥物開發、診斷和研發至關重要。該行業的成長動力主要來自治療性胜肽的進步、自動化合成技術的進步以及對個人化醫療日益成長的需求。關鍵趨勢包括固相合成技術的創新以及在腫瘤學和代謝性疾病領域應用範圍的擴大。生物技術和製藥行業的擴張將推動該市場持續成長。

受治療應用進展和研究活動日益活躍的推動，胜肽合成市場持續穩定擴張。試劑領域成長率最高，主要歸功於高品質試劑在高效合成胜肽方面發揮的關鍵作用。其中，氨基酸子領域尤其引人注目，因為氨基酸是肽鏈形成所必需的。設備領域成長率位居第二，胜肽合成儀因其自動化程度高、精度高等優點而備受關注。客製化胜肽合成服務也發展迅猛，滿足了製藥和生技公司的特定需求。對個人化醫療和標靶治療日益成長的需求是推動該領域發展的主要動力。此外，新型胜肽類藥物的研發凸顯了維持穩健的供應鏈和創新合成技術的重要性。技術進步進一步強化了市場的活力，確保合成方法的持續發展，並擴大胜肽在各個領域的潛在應用。

市場區隔
類型 固相胜肽合成、液相胜肽合成、混合及重組技術
產品 試劑、設備、樹脂、軟體
服務 客製化胜肽合成、胜肽庫設計、胜肽分析
科技 FMOC技術，BOC技術
目的 治療、診斷、研究、化妝品、食品和飼料添加劑
最終用戶 製藥和生物技術公司、學術研究機構、受託研究機構
過程 化學合成，酶促合成
材料 天然胜肽，合成胜肽
功能 抗菌胜肽、荷爾蒙胜肽、免疫調節胜肽

肽合成市場的特點是市場佔有率多元化，多家主要企業不斷推出創新產品以獲得競爭優勢。定價策略差異顯著，受技術進步和生產效率的影響。新產品頻繁發布，反映了市場的動態特性以及對專業化、高品質胜肽的持續需求。市場成長的驅動力來自製藥、生物技術和研究領域應用的不斷擴展，這使得精準性和客製化日益重要。肽合成市場的競爭異常激烈，主要企業都在研發方面投入大量資金以保持優勢。監管至關重要，遵守嚴格的標準是進入市場和永續性的關鍵。北美和歐洲等地區完善的法規結構確保了高品質的產品，但也對新進入者構成了准入障礙。肽技術的創新和在各個領域的應用不斷擴展正在推動市場成長。

主要趨勢和促進因素：

受生物技術和製藥領域進步的推動，肽合成市場正經歷強勁成長。個人化醫療需求的不斷成長是關鍵趨勢，這加速了基於胜肽的療法的研發。合成技術的創新也促進了這一趨勢，實現了更有效率、更經濟的生產流程。慢性病和癌症的日益增多推動了對新治療方法的需求，而胜肽憑藉其高特異性和高效性，被視為一種極具前景的解決方案。此外，肽療法和診斷領域研究活動的不斷拓展也推動了市場成長。政府和私人對胜肽研究的投入進一步促進了這一趨勢。提供胜肽合成服務的受託研究機構（CRO）的興起也是一個關鍵促進因素。這些組織提供專業知識和基礎設施，降低了新參與企業的市場門檻。此外，人們對基於胜肽的疫苗和診斷方法的興趣日益濃厚，尤其是在全球健康挑戰的背景下，這凸顯了該市場的巨大潛力。預計持續的研究和技術進步將推動肽合成市場持續成長。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 固相胜肽合成
    • 液相胜肽合成
    • 混合和重組技術
  • 市場規模及預測：依產品分類
    • 試劑
    • 裝置
    • 樹脂
    • 軟體
  • 市場規模及預測：依服務分類
    • 客製化胜肽合成
    • 胜肽庫設計
    • 胜肽分析
  • 市場規模及預測：依技術分類
    • FMOC技術
    • 博克科技
  • 市場規模及預測：依應用領域分類
    • 治療
    • 診斷
    • 研究
    • 化妝品
    • 食品/飼料添加劑
  • 市場規模及預測：依最終用戶分類
    • 製藥和生物技術公司
    • 學術研究機構
    • 受託研究機構
  • 市場規模及預測：依製程分類
    • 化學合成
    • 酵素合成
  • 市場規模及預測：依材料分類
    • 天然胜肽
    • 合成胜肽
  • 市場規模及預測：依功能分類
    • 抗菌胜肽
    • 荷爾蒙胜肽
    • 免疫調節胜肽

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Bachem
  • Ana Spec
  • CSBio
  • Peptide Institute
  • CEM Corporation
  • New England Peptide
  • AAPPTec
  • Gen Script
  • Bio-Synthesis
  • JPT Peptide Technologies
  • Poly Peptide Group
  • Peptide 2.0
  • Creative Peptides
  • Biotage
  • Chem Pep
  • Genscript Biotech
  • Advanced Chem Tech
  • Pro Immune
  • Life Tein
  • Pepscan

第9章：關於我們

簡介目錄
Product Code: GIS20547

Peptide Synthesis Market is anticipated to expand from $685.2 million in 2024 to $2,265.0 million by 2034, growing at a CAGR of approximately 19.3%. The Peptide Synthesis Market encompasses the production of peptides, which are chains of amino acids crucial for drug development, diagnostics, and research. This sector is driven by advancements in therapeutic peptides, automated synthesis technologies, and increasing demand for personalized medicine. Key trends include innovations in solid-phase synthesis and growing applications in oncology and metabolic disorders. The market is poised for growth due to expanding biotechnology and pharmaceutical industries.

The Peptide Synthesis Market is experiencing robust expansion, fueled by advancements in therapeutic applications and increasing research activities. The reagents segment is the top-performing segment, driven by the critical role of high-quality reagents in synthesizing peptides efficiently. Within this segment, the amino acids sub-segment stands out due to its essentiality in peptide chain formation. Instruments, the second highest-performing segment, witness significant traction, particularly peptide synthesizers, owing to their automation capabilities and precision. Custom peptide synthesis services are also gaining momentum, catering to the specific needs of pharmaceutical and biotechnology companies. The growing demand for personalized medicine and targeted therapies propels this segment forward. Additionally, the development of novel peptide-based drugs underscores the importance of maintaining robust supply chains and innovative synthesis techniques. The market's dynamic nature is further accentuated by technological advancements, ensuring the continuous evolution of synthesis methods and expanding the horizon of peptide applications across diverse sectors.

Market Segmentation
TypeSolid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis, Hybrid & Recombinant Technology
ProductReagents, Equipment, Resins, Software
ServicesCustom Peptide Synthesis, Peptide Library Design, Peptide Analysis
TechnologyFmoc Technology, Boc Technology
ApplicationTherapeutics, Diagnostics, Research, Cosmetics, Food and Feed Additives
End UserPharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations
ProcessChemical Synthesis, Enzymatic Synthesis
Material TypeNatural Peptides, Synthetic Peptides
FunctionalityAntimicrobial Peptides, Hormonal Peptides, Immuno-modulatory Peptides

The peptide synthesis market is characterized by a diverse distribution of market share, with several key players introducing innovative products to gain competitive advantage. Pricing strategies vary significantly, influenced by technological advancements and production efficiencies. New product launches are frequent, reflecting the dynamic nature of the market and the continuous demand for specialized, high-quality peptides. The market is driven by increasing applications in pharmaceuticals, biotechnology, and research, with a growing emphasis on precision and customization. Competition in the peptide synthesis market is intense, with leading companies investing heavily in research and development to maintain their edge. Regulatory influences are significant, as compliance with stringent standards is crucial for market entry and sustainability. The presence of established regulatory frameworks in regions like North America and Europe ensures high-quality outputs but also poses entry barriers for new entrants. The market is poised for growth, driven by innovations in peptide technology and expanding applications across various sectors.

Geographical Overview:

The peptide synthesis market is witnessing notable growth across various regions, each presenting unique opportunities. North America leads the market, driven by advancements in biotechnology and pharmaceutical research. The region's robust healthcare infrastructure and significant R&D investments are pivotal to its dominance. Europe follows, with a strong focus on innovative drug development and personalized medicine, enhancing its market position. In Asia Pacific, the market is expanding rapidly, fueled by rising healthcare expenditures and increasing demand for novel therapeutics. Countries like China and India are emerging as key players due to their growing biotech industries and government support for pharmaceutical research. Latin America and the Middle East & Africa are also showing promise, with increasing investments in healthcare infrastructure and biotechnology. Brazil and South Africa are poised to become significant contributors, leveraging their expanding pharmaceutical sectors and improving research capabilities. These growth pockets offer lucrative opportunities for stakeholders in the peptide synthesis market.

Global tariffs and geopolitical tensions are significantly influencing the peptide synthesis market, particularly in East Asia. Japan and South Korea are increasingly investing in domestic R&D to mitigate reliance on imported raw materials, while China is focused on enhancing its self-sufficiency through government-backed biotech initiatives. Taiwan remains pivotal due to its advanced manufacturing capabilities but is vulnerable to cross-strait tensions. The global peptide synthesis market is witnessing robust growth driven by pharmaceutical advancements and therapeutic innovations. By 2035, the market is expected to expand through strategic regional collaborations and technological advancements. Concurrently, Middle East conflicts are contributing to volatility in energy prices, indirectly affecting manufacturing costs and supply chain stability. Strategic diversification and energy-efficient practices will be crucial for sustained growth.

Key Trends and Drivers:

The peptide synthesis market is experiencing robust growth, driven by advancements in biotechnology and pharmaceuticals. Key trends include the increasing demand for personalized medicine, which is accelerating the development of peptide-based therapeutics. This trend is complemented by innovations in synthesis technologies, enabling more efficient and cost-effective production processes. The rise in chronic diseases and cancer has heightened the need for novel treatment options, positioning peptides as a promising solution due to their high specificity and efficacy. Additionally, the expansion of research activities in peptide therapeutics and diagnostics is fueling market expansion. Government funding and private investments in peptide research further support this trajectory. The proliferation of contract research organizations (CROs) offering peptide synthesis services is another significant driver. These organizations provide expertise and infrastructure, lowering entry barriers for new market participants. Furthermore, the growing interest in peptide-based vaccines and diagnostics, particularly in the wake of global health challenges, underscores the market's potential. With ongoing research and technological advancements, the peptide synthesis market is poised for sustained growth.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Material Type
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Solid Phase Peptide Synthesis
    • 4.1.2 Liquid Phase Peptide Synthesis
    • 4.1.3 Hybrid & Recombinant Technology
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Reagents
    • 4.2.2 Equipment
    • 4.2.3 Resins
    • 4.2.4 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Custom Peptide Synthesis
    • 4.3.2 Peptide Library Design
    • 4.3.3 Peptide Analysis
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Fmoc Technology
    • 4.4.2 Boc Technology
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Therapeutics
    • 4.5.2 Diagnostics
    • 4.5.3 Research
    • 4.5.4 Cosmetics
    • 4.5.5 Food and Feed Additives
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Pharmaceutical and Biotechnology Companies
    • 4.6.2 Academic and Research Institutes
    • 4.6.3 Contract Research Organizations
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Chemical Synthesis
    • 4.7.2 Enzymatic Synthesis
  • 4.8 Market Size & Forecast by Material Type (2020-2035)
    • 4.8.1 Natural Peptides
    • 4.8.2 Synthetic Peptides
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Antimicrobial Peptides
    • 4.9.2 Hormonal Peptides
    • 4.9.3 Immuno-modulatory Peptides

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Material Type
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Material Type
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Material Type
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Material Type
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Material Type
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Material Type
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Material Type
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Material Type
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Material Type
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Material Type
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Material Type
      • 5.4.5.9 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Material Type
      • 5.4.6.9 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Material Type
      • 5.4.7.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Material Type
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Material Type
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Material Type
      • 5.5.3.9 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Material Type
      • 5.5.4.9 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Material Type
      • 5.5.5.9 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Material Type
      • 5.5.6.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Material Type
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Material Type
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Material Type
      • 5.6.3.9 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Material Type
      • 5.6.4.9 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Material Type
      • 5.6.5.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Bachem
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Ana Spec
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 CSBio
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Peptide Institute
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 CEM Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 New England Peptide
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 AAPPTec
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Gen Script
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Bio- Synthesis
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 JPT Peptide Technologies
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Poly Peptide Group
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Peptide 2.0
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Creative Peptides
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Biotage
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Chem Pep
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Genscript Biotech
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Advanced Chem Tech
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Pro Immune
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Life Tein
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Pepscan
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us